Endpoint Clinical is a global leader in Randomization and Trial Supply Management (RTSM) solutions for clinical trials. Founded in 2009 and headquartered in Raleigh, North Carolina, the company operates across the United States, Europe, and Asia with a team of over 600 professionals. Its technology platform serves the life sciences sector, supporting more than 2,000 studies across 90,000+ sites in over 90 countries, managing over 650,000 patients.
The company's core product offerings include PULSE, which provides configurable, pre-validated components for rapid deployment of RTSM solutions, and Elosity, designed to ensure seamless study start-up with elasticity and velocity. Both products address the critical technical domain of randomization and trial supply management, a specialized area within clinical trial technology and clinical operations.
Endpoint Clinical's technical work centers on building and maintaining software systems that handle the randomization of patients in clinical studies and the management of investigational product supply chains. The scale of its operations - spanning tens of thousands of sites and hundreds of thousands of patients globally - indicates a platform built for high reliability and complex logistics across diverse regulatory environments.
